应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
APVO Aptevo Therapeutics Inc.
未开盘 05-06 16:00:00 EDT
0.4100
-0.0300
-6.82%
盘后
0.4129
+0.0029
+0.71%
19:49 EDT
最高
0.4245
最低
0.3999
成交量
58.92万
今开
0.4245
昨收
0.4400
日振幅
5.59%
总市值
256.66万
流通市值
223.86万
总股本
626.01万
成交额
24.25万
换手率
10.79%
流通股本
545.99万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Aptevo Therapeutics Inc.5月5日成交额为169.69万美元
市场透视 · 05-06 01:16
Aptevo Therapeutics Inc.5月5日成交额为169.69万美元
Aptevo Therapeutics Inc.股价重挫13.63% 市值跌32.68万美元
市场透视 · 05-05 13:32
Aptevo Therapeutics Inc.股价重挫13.63% 市值跌32.68万美元
Aptevo Therapeutics Inc.盘中异动 股价大涨5.07%报0.524美元
市场透视 · 05-02
Aptevo Therapeutics Inc.盘中异动 股价大涨5.07%报0.524美元
Aptevo Therapeutics Inc.4月30日成交额为47.05万美元
市场透视 · 05-01
Aptevo Therapeutics Inc.4月30日成交额为47.05万美元
Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.65%报0.534美元
市场透视 · 04-30
Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.65%报0.534美元
Aptevo Therapeutics Inc.盘中异动 股价大跌5.42%
市场透视 · 04-29
Aptevo Therapeutics Inc.盘中异动 股价大跌5.42%
Aptevo Therapeutics Inc.盘中异动 下午盘股价大涨12.20%报0.778美元
市场透视 · 04-23
Aptevo Therapeutics Inc.盘中异动 下午盘股价大涨12.20%报0.778美元
Aptevo Therapeutics Inc.盘中异动 大幅上涨6.09%报0.674美元
市场透视 · 04-22
Aptevo Therapeutics Inc.盘中异动 大幅上涨6.09%报0.674美元
Aptevo Therapeutics Inc.4月21日成交额为6387.58万美元
市场透视 · 04-22
Aptevo Therapeutics Inc.4月21日成交额为6387.58万美元
Aptevo Therapeutics Inc.股价上涨28.83% 市值涨103.18万美元
市场透视 · 04-21
Aptevo Therapeutics Inc.股价上涨28.83% 市值涨103.18万美元
Aptevo Therapeutics Inc.盘中异动 早盘快速跳水5.67%
市场透视 · 04-15
Aptevo Therapeutics Inc.盘中异动 早盘快速跳水5.67%
Aptevo Therapeutics Inc.盘中异动 早盘急速拉升7.92%
市场透视 · 04-14
Aptevo Therapeutics Inc.盘中异动 早盘急速拉升7.92%
Aptevo Therapeutics Inc.盘中异动 下午盘股价大跌6.68%报2.59美元
市场透视 · 03-06
Aptevo Therapeutics Inc.盘中异动 下午盘股价大跌6.68%报2.59美元
Aptevo Therapeutics Inc.盘中异动 下午盘快速下挫5.88%
市场透视 · 03-04
Aptevo Therapeutics Inc.盘中异动 下午盘快速下挫5.88%
Aptevo Therapeutics Inc.盘中异动 临近午盘快速下跌8.38%
市场透视 · 03-03
Aptevo Therapeutics Inc.盘中异动 临近午盘快速下跌8.38%
Aptevo Therapeutics Inc.盘中异动 快速拉升5.85%报3.80美元
市场透视 · 02-28
Aptevo Therapeutics Inc.盘中异动 快速拉升5.85%报3.80美元
Aptevo Therapeutics Inc.盘中异动 股价大涨6.38%报3.50美元
市场透视 · 02-27
Aptevo Therapeutics Inc.盘中异动 股价大涨6.38%报3.50美元
Aptevo Therapeutics Inc.盘中异动 早盘快速上涨5.54%报3.24美元
市场透视 · 02-26
Aptevo Therapeutics Inc.盘中异动 早盘快速上涨5.54%报3.24美元
Aptevo Therapeutics Inc.盘中异动 早盘大幅上涨5.14%
市场透视 · 02-25
Aptevo Therapeutics Inc.盘中异动 早盘大幅上涨5.14%
Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.48%报3.28美元
市场透视 · 02-24
Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.48%报3.28美元
加载更多
公司概况
公司名称:
Aptevo Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司,专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术,用于合理设计精准免疫调节药物。该公司的主要临床候选药物APVO436和ALG.APV-527以及临床前候选药物APVO603和APVO711是使用ADAPTIR模块蛋白技术平台开发的。该公司的临床前候选药物APVO442是利用ADAPTIR-FLEX模块蛋白技术平台开发的。该公司的ADAPTIR和ADAPTIR-FLEX平台旨在产生能够增强人体免疫系统对抗癌细胞的单特异性、双特异性和多特异性候选抗体。
发行价格:
--
{"stockData":{"symbol":"APVO","market":"US","secType":"STK","nameCN":"Aptevo Therapeutics Inc.","latestPrice":0.41,"timestamp":1746561600000,"preClose":0.44,"halted":0,"volume":589235,"hourTrading":{"tag":"盘后","latestPrice":0.4129,"preClose":0.41,"latestTime":"19:49 EDT","volume":7225,"amount":2936.045,"timestamp":1746575361318},"delay":0,"floatShares":5459900,"shares":6260100,"eps":-87.38416,"marketStatus":"未开盘","change":-0.03,"latestTime":"05-06 16:00:00 EDT","open":0.4245,"high":0.4245,"low":0.3999,"amount":242518.72600224998,"amplitude":0.055909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-87.38416,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.44,"preHourTrading":{"tag":"盘前","latestPrice":0.4297,"preClose":0.44,"latestTime":"09:24 EDT","volume":18640,"amount":7928.9068656,"timestamp":1746537842101},"postHourTrading":{"tag":"盘后","latestPrice":0.4129,"preClose":0.41,"latestTime":"19:49 EDT","volume":7225,"amount":2936.045,"timestamp":1746575361318},"volumeRatio":0.457359},"requestUrl":"/m/hq/s/APVO","defaultTab":"news","newsList":[{"id":"2533592977","title":"Aptevo Therapeutics Inc.5月5日成交额为169.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533592977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533592977?lang=zh_cn&edition=full","pubTime":"2025-05-06 09:16","pubTimestamp":1746494177,"startTime":"0","endTime":"0","summary":"美东时间2025年5月5日,Aptevo Therapeutics Inc.成交额为169.69万美元,成交额较昨日增加383.67%,当日成交量为378.22万股。Aptevo Therapeutics Inc.于2025年5月5日跌12.09%,报0.44美元,该股过去5个交易日跌28.1%,年初至今跌89.79%,过去60日跌89.79%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-05|169.69万|383.67%|378.22万|#|2025-05-02|35.08万|67.43%|74.30万|#|2025-05-01|20.95万|-55.46%|41.87万|#|2025-04-30|47.05万|47.63%|93.09万|#|2025-04-29|31.87万|-16.95%|56.70万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506091623a47350f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506091623a47350f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","APVO"],"gpt_icon":0},{"id":"2533612587","title":"Aptevo Therapeutics Inc.股价重挫13.63% 市值跌32.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533612587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533612587?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:32","pubTimestamp":1746451924,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时32分,Aptevo Therapeutics Inc.股票出现波动,股价大幅下跌13.63%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.18%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Nucana Plc涨幅较大,Nucana Plc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃,换手率分别为683.40%、257.03%、42.97%,振幅较大的相关个股有Polyrizon Ltd.、Nucana Plc、Scisparc Ltd.,振幅分别为21.80%、21.16%、11.76%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213204a472d788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213204a472d788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","APVO"],"gpt_icon":0},{"id":"2532384063","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨5.07%报0.524美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532384063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532384063?lang=zh_cn&edition=full","pubTime":"2025-05-02 22:14","pubTimestamp":1746195241,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日22时14分,Aptevo Therapeutics Inc.股票出现异动,股价急速上涨5.07%。截至发稿,该股报0.524美元/股,成交量13.6579万股,换手率2.46%,振幅5.99%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.99%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502221401a4700bc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502221401a4700bc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO","BK4007"],"gpt_icon":0},{"id":"2532801762","title":"Aptevo Therapeutics Inc.4月30日成交额为47.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532801762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532801762?lang=zh_cn&edition=full","pubTime":"2025-05-01 09:16","pubTimestamp":1746062178,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日,Aptevo Therapeutics Inc.成交额为47.05万美元,成交额较昨日增加47.63%,当日成交量为93.09万股。Aptevo Therapeutics Inc.于2025年4月30日跌6.36%,报0.53美元,该股过去5个交易日跌28.38%,年初至今跌87.7%,过去60日跌87.82%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-30|47.05万|47.63%|93.09万|#|2025-04-29|31.87万|-16.95%|56.70万|#|2025-04-28|38.38万|41.02%|62.63万|#|2025-04-25|27.21万|-25.72%|41.54万|#|2025-04-24|36.64万|-36.58%|53.23万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091627a6cf8399&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501091627a6cf8399&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4007","BK4139"],"gpt_icon":0},{"id":"2531538700","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.65%报0.534美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531538700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531538700?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:32","pubTimestamp":1746019953,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时32分,Aptevo Therapeutics Inc.股票出现异动,股价快速下跌5.65%。截至发稿,该股报0.534美元/股,成交量2.772万股,换手率0.50%,振幅3.18%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.27%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213234aa2c7f42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213234aa2c7f42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2531755293","title":"Aptevo Therapeutics Inc.盘中异动 股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531755293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531755293?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:52","pubTimestamp":1745934724,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时52分,Aptevo Therapeutics Inc.股票出现异动,股价大幅跳水5.42%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.30%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215204aa2c7e1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215204aa2c7e1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4007","BK4139"],"gpt_icon":0},{"id":"2529516626","title":"Aptevo Therapeutics Inc.盘中异动 下午盘股价大涨12.20%报0.778美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529516626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529516626?lang=zh_cn&edition=full","pubTime":"2025-04-24 02:05","pubTimestamp":1745431515,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日02时05分,Aptevo Therapeutics Inc.股票出现波动,股价大幅拉升12.20%。截至发稿,该股报0.778美元/股,成交量52.7765万股,换手率16.37%,振幅9.69%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042402051594dfe4d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042402051594dfe4d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","APVO"],"gpt_icon":0},{"id":"2529658216","title":"Aptevo Therapeutics Inc.盘中异动 大幅上涨6.09%报0.674美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529658216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529658216?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:47","pubTimestamp":1745329634,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时47分,Aptevo Therapeutics Inc.股票出现波动,股价大幅拉升6.09%。截至发稿,该股报0.674美元/股,成交量57.3008万股,换手率17.78%,振幅2.89%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.30%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214714a6c3de68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422214714a6c3de68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","APVO"],"gpt_icon":0},{"id":"2529398591","title":"Aptevo Therapeutics Inc.4月21日成交额为6387.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529398591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529398591?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:16","pubTimestamp":1745284566,"startTime":"0","endTime":"0","summary":"美东时间2025年4月21日,Aptevo Therapeutics Inc.成交额为6387.58万美元,成交额较昨日增加43135.28%,当日成交量为5708.55万股。Aptevo Therapeutics Inc.于2025年4月21日跌26.24%,报0.636美元,该股过去5个交易日跌37.06%,年初至今跌85.25%,过去60日跌86.21%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-04-21|6387.58万|43135.28%|5708.55万|#|2025-04-17|14.77万|-36.91%|17.36万|#|2025-04-16|23.42万|-31.42%|26.14万|#|2025-04-15|34.15万|14.03%|34.97万|#|2025-04-14|29.94万|10.41%|28.53万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422091618a6c30cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422091618a6c30cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","APVO"],"gpt_icon":0},{"id":"2529385055","title":"Aptevo Therapeutics Inc.股价上涨28.83% 市值涨103.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529385055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529385055?lang=zh_cn&edition=full","pubTime":"2025-04-21 21:31","pubTimestamp":1745242274,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日21时31分,Aptevo Therapeutics Inc.股票出现异动,股价大幅拉升28.83%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大,Aptevo Therapeutics Inc.、Evogene Ltd.、Transcode Therapeutics, Inc.较为活跃,换手率分别为529.54%、178.96%、105.06%,振幅较大的相关个股有Xenon制药、Naya Biosciences, Inc.、Processa Pharmaceuticals, Inc.,振幅分别为7.41%、6.77%、6.41%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213114a4611c60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421213114a4611c60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","APVO"],"gpt_icon":1},{"id":"2527454804","title":"Aptevo Therapeutics Inc.盘中异动 早盘快速跳水5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527454804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527454804?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:34","pubTimestamp":1744727692,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时34分,Aptevo Therapeutics Inc.股票出现波动,股价快速下跌5.67%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415223452a459d661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415223452a459d661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","LENZ","BK4007"],"gpt_icon":0},{"id":"2527164883","title":"Aptevo Therapeutics Inc.盘中异动 早盘急速拉升7.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527164883?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:34","pubTimestamp":1744637669,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时34分,Aptevo Therapeutics Inc.股票出现异动,股价急速上涨7.92%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.07%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Theratechnologies Inc.、Third Harmonic Bio, Inc.涨幅较大,Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃,换手率分别为277.60%、134.48%、86.93%,振幅较大的相关个股有Verrica制药、Neuraxis, Inc.、Verve Therapeutics, Inc.,振幅分别为17.60%、15.64%、15.33%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213430aa2c6e26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213430aa2c6e26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO","BK4007"],"gpt_icon":0},{"id":"2517197972","title":"Aptevo Therapeutics Inc.盘中异动 下午盘股价大跌6.68%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517197972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517197972?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:28","pubTimestamp":1741289314,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时28分,Aptevo Therapeutics Inc.股票出现波动,股价急速跳水6.68%。截至发稿,该股报2.59美元/股,成交量2.5087万股,换手率1.72%,振幅5.25%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.72%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307032834a262d671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APVO"],"gpt_icon":0},{"id":"2517983456","title":"Aptevo Therapeutics Inc.盘中异动 下午盘快速下挫5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517983456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517983456?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:57","pubTimestamp":1741118267,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时57分,Aptevo Therapeutics Inc.股票出现异动,股价急速跳水5.88%。截至发稿,该股报2.91美元/股,成交量2.9196万股,换手率2.00%,振幅5.83%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.11%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305035747a25f5f02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4139","LENZ"],"gpt_icon":0},{"id":"2516655136","title":"Aptevo Therapeutics Inc.盘中异动 临近午盘快速下跌8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516655136?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:39","pubTimestamp":1741019963,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时39分,Aptevo Therapeutics Inc.股票出现异动,股价急速跳水8.38%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.32%。其相关个股中,Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为3922.52%、173.32%、141.87%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.,振幅分别为206.20%、94.90%、70.53%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003923abe65b30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2514937376","title":"Aptevo Therapeutics Inc.盘中异动 快速拉升5.85%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514937376?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:41","pubTimestamp":1740757316,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时41分,Aptevo Therapeutics Inc.股票出现异动,股价快速拉升5.85%。截至发稿,该股报3.80美元/股,成交量2.7148万股,换手率1.86%,振幅6.13%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282341579896898f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2514738573","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨6.38%报3.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514738573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514738573?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:37","pubTimestamp":1740667074,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时37分,Aptevo Therapeutics Inc.股票出现波动,股价大幅上涨6.38%。截至发稿,该股报3.50美元/股,成交量7331股,换手率0.50%,振幅0.91%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.85%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223754a2567bc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APVO"],"gpt_icon":0},{"id":"2514856074","title":"Aptevo Therapeutics Inc.盘中异动 早盘快速上涨5.54%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856074?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580444,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分,Aptevo Therapeutics Inc.股票出现异动,股价快速上涨5.54%。截至发稿,该股报3.24美元/股,成交量2465股,换手率0.17%,振幅0.00%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.21%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223404a254f72d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APVO","BK4139"],"gpt_icon":0},{"id":"2514013592","title":"Aptevo Therapeutics Inc.盘中异动 早盘大幅上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013592?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494665,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分,Aptevo Therapeutics Inc.股票出现波动,股价快速拉升5.14%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.37%。其相关个股中,Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为855.06%、620.78%、532.76%,振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.,振幅分别为100.27%、46.65%、33.50%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224425962ff596&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224425962ff596&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0},{"id":"2513720430","title":"Aptevo Therapeutics Inc.盘中异动 早盘股价大跌5.48%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720430?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:08","pubTimestamp":1740409697,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时08分,Aptevo Therapeutics Inc.股票出现异动,股价大幅下挫5.48%。截至发稿,该股报3.28美元/股,成交量1.106万股,换手率0.76%,振幅4.32%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家处于临床研究开发阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230818962ea200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230818962ea200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aptevotherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.2756},{"period":"1month","weight":-0.7248},{"period":"3month","weight":-0.9002},{"period":"6month","weight":-0.9641},{"period":"1year","weight":-0.99},{"period":"ytd","weight":-0.9049}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.1059},{"period":"3month","weight":-0.0752},{"period":"6month","weight":-0.0618},{"period":"1year","weight":0.0818},{"period":"ytd","weight":-0.0465}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司,专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术,用于合理设计精准免疫调节药物。该公司的主要临床候选药物APVO436和ALG.APV-527以及临床前候选药物APVO603和APVO711是使用ADAPTIR模块蛋白技术平台开发的。该公司的临床前候选药物APVO442是利用ADAPTIR-FLEX模块蛋白技术平台开发的。该公司的ADAPTIR和ADAPTIR-FLEX平台旨在产生能够增强人体免疫系统对抗癌细胞的单特异性、双特异性和多特异性候选抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.073503},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.064327},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.20989},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.15126},{"month":5,"riseRate":0.555556,"avgChangeRate":0.009749},{"month":6,"riseRate":0.25,"avgChangeRate":-0.053513},{"month":7,"riseRate":0.5,"avgChangeRate":-0.035974},{"month":8,"riseRate":0.125,"avgChangeRate":-0.135772},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.070045},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.010761},{"month":11,"riseRate":0.555556,"avgChangeRate":0.546943},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.110269}],"exchange":"NASDAQ","name":"Aptevo Therapeutics Inc.","nameEN":"Aptevo Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.3","shortVersion":"4.33.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aptevo Therapeutics Inc.,APVO,Aptevo Therapeutics Inc.股票,Aptevo Therapeutics Inc.股票老虎,Aptevo Therapeutics Inc.股票老虎国际,Aptevo Therapeutics Inc.行情,Aptevo Therapeutics Inc.股票行情,Aptevo Therapeutics Inc.股价,Aptevo Therapeutics Inc.股市,Aptevo Therapeutics Inc.股票价格,Aptevo Therapeutics Inc.股票交易,Aptevo Therapeutics Inc.股票购买,Aptevo Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}